Skip to Content
Merck
CN
  • A genome-based approach to create a minimally mutated Corynebacterium glutamicum strain for efficient L-lysine production.

A genome-based approach to create a minimally mutated Corynebacterium glutamicum strain for efficient L-lysine production.

Journal of industrial microbiology & biotechnology (2006-03-01)
Masato Ikeda, Junko Ohnishi, Mikiro Hayashi, Satoshi Mitsuhashi
ABSTRACT

Based on the progress in genomics, we have developed a novel approach that employs genomic information to generate an efficient amino acid producer. A comparative genomic analysis of an industrial L-lysine producer with its natural ancestor identified a variety of mutations in genes associated with L-lysine biosynthesis. Among these mutations, we identified two mutations in the relevant terminal pathways as key mutations for L-lysine production, and three mutations in central metabolism that resulted in increased titers. These five mutations when assembled in the wild-type genome led to a significant increase in both the rate of production and final L-lysine titer. Further investigations incorporated with transcriptome analysis suggested that other as yet unidentified mutations are necessary to support the L-lysine titers observed by the original production strain. Here we describe the essence of our approach for strain reconstruction, and also discuss mechanisms of L-lysine hyperproduction unraveled by combining genomics with classical strain improvement.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
L-Lysine, crystallized, ≥98.0% (NT)
Sigma-Aldrich
L-Lysine, ≥98% (TLC)
Sigma-Aldrich
L-Lysine, Vetec, reagent grade, ≥98%
Supelco
L-Lysine, analytical standard